2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
出版年份 2012 全文链接
标题
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
作者
关键词
-
出版物
ARTHRITIS CARE & RESEARCH
Volume 64, Issue 10, Pages 1447-1461
出版商
Wiley
发表日期
2012-09-30
DOI
10.1002/acr.21773
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
- (2012) Frances Rees et al. ANNALS OF THE RHEUMATIC DISEASES
- Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
- (2012) H. Ralph Schumacher et al. ARTHRITIS AND RHEUMATISM
- Efficacy and Tolerability of Celecoxib in the Treatment of Acute Gouty Arthritis: A Randomized Controlled Trial
- (2012) H. R. SCHUMACHER et al. JOURNAL OF RHEUMATOLOGY
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Management of Gout in the Older Adult
- (2011) Michelle A. Fravel et al. American Journal Geriatric Pharmacotherapy
- Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
- (2011) Robert T. Keenan et al. AMERICAN JOURNAL OF MEDICINE
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
- (2011) N. Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors
- (2011) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
- (2011) Yanyan Zhu et al. ARTHRITIS AND RHEUMATISM
- Developing a provisional definition of flare in patients with established gout
- (2011) Angelo L. Gaffo et al. ARTHRITIS AND RHEUMATISM
- Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
- (2011) Robert L. Wortmann et al. CLINICAL THERAPEUTICS
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comorbidities in Patients with Gout
- (2011) Naomi Ichikawa et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies
- (2011) Luis Alberto García Rodríguez et al. PLoS One
- Nouveaux traitements de la goutte
- (2011) Pascal Richette et al. PRESSE MEDICALE
- Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
- (2011) Naomi Schlesinger et al. ARTHRITIS RESEARCH & THERAPY
- High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study
- (2010) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study
- (2010) Alexander So et al. ARTHRITIS AND RHEUMATISM
- Chronic gout: epidemiology, disease progression, treatment and disease burden
- (2010) Richard A. Brook et al. CURRENT MEDICAL RESEARCH AND OPINION
- Oral Colchicine (Colcrys®)
- (2010) Lily P.H. Yang DRUGS
- Update on gout: new therapeutic strategies and options
- (2010) Robert Terkeltaub Nature Reviews Rheumatology
- Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases
- (2010) Kun Chen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
- Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy
- (2010) N.L. Edwards et al. JOURNAL OF MEDICAL ECONOMICS
- Oral prednisolone is more cost-effective than oral indomethacin for treating patients with acute gout-like arthritis
- (2009) Giles N. Cattermole et al. European Journal of Emergency Medicine
- Progress in Measurement Instruments for Acute and Chronic Gout Studies
- (2009) R. GRAINGER et al. JOURNAL OF RHEUMATOLOGY
- Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
- (2008) Hein JEM Janssens et al. LANCET
- Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy
- (2008) Michael A. Becker et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions
- (2008) Becky A Briesacher et al. PHARMACOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started